Akso Health Group

AHG | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.29

+$0.08 (+6.61%)

At close: Nov 5, 2026, 4:00 PM ET

$1.31

+$0.02 (+1.55%)

After-hours: Nov 5, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.11B

Enterprise Value $1.15B

Beta -1.01

Average Volume 80.92K

Shares Outstanding (Diluted) 722.71M

Shares Change YoY 114.34%

Institutional Ownership 0.04%

Exchange NASDAQ

ISIN US98422P1084

Price Performance

Price Change 1M 10.3%

Price Change 3M -2.3%

Price Change 6M -37.1%

Price Change YTD -21.3%

Price Change 1Y -23.7%

Price Change 3Y 17.3%

Price Change 5Y -70.2%

1M CAGR (ann.) 72.4%

1Y CAGR (ann.) -21.6%

5Y CAGR (ann.) -27.4%

All-Time CAGR -39.0%

Valuation

PE Ratio -18.29

Forward PE 0.34

PEG Ratio -0.12

Forward PEG -0.12

PS Ratio 83.36

Forward PS 10.60

PB Ratio 6.37

P/FCF Ratio -10.84

P/Adj. FCF Ratio -10.84

P/OCF Ratio -45.00

EV/Sales 83.37

EV/EBIT -288.29

EV/EBITDA -708.14

EV/FCF -10.84

Earnings Yield -5.5%

FCF Yield -9.2%

Adj. FCF Yield -9.2%

Financial Health

Net Debt $179.96K

Total Debt $375.66K

Cash & Short-Term Investments $170.57K

Total Assets $189.63M

Current Ratio 21.77

Quick Ratio 21.74

Debt / Equity Ratio 0.00

Debt / EBITDA -0.23

Debt / FCF -0.00

OCF / Debt -49.44

Interest Coverage 0.00

Altman Z-Score 77.78

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin -0.1%

Operating Profit Margin -28.9%

EBITDA Margin -11.8%

Net Profit Margin -207.1%

FCF Margin -769.3%

Adj. FCF Margin -769.3%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -15.1%

Return on Equity -15.1%

Return on Invested Capital -1.9%

Return on Capital Employed -2.2%

Return on Tangible Assets -15.1%

Historical Growth (CAGR)

Revenue CAGR 3Y 1.6%

Revenue CAGR 5Y 17.2%

Revenue CAGR 10Y 1.5%

EPS CAGR 3Y 76.2%

EPS CAGR 5Y -350.2%

EPS CAGR 10Y -18.2%

FCF CAGR 3Y -155.4%

FCF CAGR 5Y -68.5%

FCF CAGR 10Y -58.1%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y -138.1%

Revenue Growth Next 3Y 36.8%

Earnings Date Dec 2, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $0.00

Price Target Upside N/A

Cash Flow

Operating Cash Flow $-18.57M

Free Cash Flow $-106.41M

Adj. Free Cash Flow $-106.41M

FCF Per Share -$0.15

OCF Per Share -$0.03

OCF/S Ratio -134.3%

Income Statement

Revenue $13.83M

Gross Profit $-11.32K

Operating Income $-4M

EBITDA $-1.63M

Net Income $-28.65M

EPS (Diluted) -$0.07

Revenue / Employee $1.15M

Profit / Employee $-2.39M

Employees 12